Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein
Journal of Virology · 2024
DOI: 10.1128/jvi.00524-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Ieva Bagdonaite und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Medicine, Copenhagen Center for Glycomics, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Ebolavirus, Virus Replication, Polysaccharides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission (EC), Lundbeck Foundation (Lundbeckfonden), Innovative Medicines Initiative 2 Joint Undertaking.
Abstract (Originalsprache)
Ebola virus glycoprotein (EBOV GP) is one of the most heavily O-glycosylated viral glycoproteins, yet we still lack a fundamental understanding of the structure of its large O-glycosylated mucin-like domain and to what degree the host O-glycosylation capacity influences EBOV replication. Using tandem mass spectrometry, we identified 47 O-glycosites on EBOV GP and found similar glycosylation signatures on virus-like particle- and cell lysate-derived GP. Furthermore, we performed quantitative differential O-glycoproteomics on proteins produced in wild-type HEK293 cells and cell lines ablated for the three key initiators of O-linked glycosylation, GalNAc-T1, -T2, and -T3. The data show that 12 out of the 47 O-glycosylated sites were regulated, predominantly by GalNAc-T1. Using the glycoengineered cell lines for authentic EBOV propagation, we demonstrate the importance of O-linked glycan initiation and elongation for the production of viral particles and the titers of progeny virus. The mapped O-glycan positions and structures allowed to generate molecular dynamics simulations probing the largely unknown spatial arrangements of the mucin-like domain. The data highlight targeting GALNT1 or C1GALT1C1 as a possible way to modulate O-glycan density on EBOV GP for novel vaccine designs and tailored intervention approaches. IMPORTANCE Ebola virus glycoprotein acquires its extensive glycan shield in the host cell, where it is decorated with N-linked glycans and mucin-type O-linked glycans. The latter is initiated by a family of polypeptide GalNAc-transferases that have different preferences for optimal peptide substrates resulting in a spectrum of both very selective and redundant substrates for each isoform. In this work, we map the exact locations of O-glycans on Ebola virus glycoprotein and identify subsets of sites preferentially initiated by one of the three key isoforms of GalNAc-Ts, demonstrating that each enzyme contributes to the glycan shield integrity. We further show that altering host O-glycosylation capacity has detrimental effects on Ebola virus replication, with both isoform-specific initiation and elongation playing a role. The combined structural and functional data highlight glycoengineered cell lines as useful tools for investigating molecular mechanisms imposed by specific glycans and for steering the immune responses in future vaccine designs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Medicine, Copenhagen Center for Glycomics, University of Copenhagen, Copenhagen, Denmark.
- Public Health Agency of Sweden, Solna, Sweden.
- Department of Molecular Medicine, University of Padua, Padua, Italy.
- Biognos AB, Gothenburg, Sweden.
- Department of Laboratory Medicine (LABMED), Karolinska Institute, Stockholm, Sweden.
- National Veterinary Institute, Uppsala, Sweden.
ORCID-Profile: Ieva Bagdonaite, Cristiano Salata, Ali Mirazimi, Hans H Wandall
Förderung
- European Commission (EC)
- Lundbeck Foundation (Lundbeckfonden)
- Innovative Medicines Initiative 2 Joint Undertaking
- Università degli Studi di Padova (UNIPD)
- Neye Foundation
Zitieren
APA
Bagdonaite, I., Abdurahman, S., Mirandola, M., Pasqual, D., Frank, M., Narimatsu, Y., Joshi, H. J., Vakhrushev, S. Y., Salata, C., Mirazimi, A., & Wandall, H. H. (2024). Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein. Journal of Virology. https://doi.org/10.1128/jvi.00524-24
Vancouver
Bagdonaite I, Abdurahman S, Mirandola M, Pasqual D, Frank M, Narimatsu Y, et al. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein. Journal of Virology. 2024. doi:10.1128/jvi.00524-24
BibTeX
@article{Bagdonaite2024,
author = {Bagdonaite, Ieva and Abdurahman, Samir and Mirandola, Mattia and Pasqual, Denis and Frank, Martin and Narimatsu, Yoshiki and Joshi, Hiren J and Vakhrushev, Sergey Y and Salata, Cristiano and Mirazimi, Ali and Wandall, Hans H},
title = {Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.00524-24}
}
EUVIMED